Genome-wide DNA methylation level was studied to determine whether multiple sclerosis patients (cases) has methylation differences comparing to normal controls in PBLs. We used Illumina HumanMethylati
DNA methylation from three protocols for neural-like cells derived from adipose stem cells (hASC) Overall design: The study aimed to compare the DNA methylation differences between three culture media
